Skip To Content

ACD/Labs Blog

Toronto, CANADA (Nov. 1, 2021)—ACD/Labs, an informatics company that develops and commercializes software in support of R&D, today announced the much-anticipated release of the first commercial browser-based NMR processing software, Spectrus JS. Announced in March 2021, Spectrus JS brings NMR processing tools users know and love from the desktop to the browser. Users can securely process...

Externalization of R&D activities and the deluge of instrumental analytical data generated on a daily basis has resulted in increasing interest in analytical data standardization. Any standardization efforts, however, to either a single format or for data exchange between formats; should be weighed against the requirements of different users of that data, and hardware innovations....

New generation of software brings higher productivity and efficiency to analytical laboratories, while adding complete, accessible, and re-usable analytical characterization to the modern informatics environment. Toronto, Canada (March 12, 2012)—Advanced Chemistry Development, Inc., (ACD/Labs) is pleased to announce the impending release of the initial lineup of ACD/Labs Spectrus Workbooks, the next element of the ACD/Spectrus...

ACD/Labs unveils work on ACD/Spectrus, a new software platform poised to dramatically improve scientific productivity and collaboration. Toronto, Canada (March 14, 2011)—Advanced Chemistry Development, Inc., (ACD/Labs) makes public their development strategy for ACD/Spectrus, a new analytical chemistry software platform based on ACD/Labs’ broadly used data handling software. Components of the ACD/Spectrus platform will be introduced...

Toronto, CA (November 25, 2008)—Sanofi-Aventis, one of the world’s leading pharmaceutical companies, recently agreed to a three-year contract to extend the use of Advanced Chemistry Development, Inc., (ACD/Labs) software throughout its R&D sites worldwide. The agreement includes provisions for continuing support, and a special pricing structure beneficial to both companies. Sanofi-Aventis uses a range of...